Literature DB >> 4055584

Age-related augmentation of plasma catecholamines during dynamic exercise in healthy males.

J L Fleg, S P Tzankoff, E G Lakatta.   

Abstract

Although plasma norepinephrine (NE) increases with age in response to a variety of submaximal adrenergic stimuli, the effect of age on plasma catecholamine levels during maximal aerobic effort and during submaximal work at a fixed percent of peak O2 consumption (VO2) is unknown. We therefore measured NE, epinephrine (E), and VO2 at rest and during graded maximal treadmill exercise in 24 healthy male volunteers (ages 22-77 yr) from the Baltimore Longitudinal Study of Aging who were rigorously screened to exclude the presence of cardiovascular disease. At rest neither heart rate (HR) nor VO2 were age related. Resting NE (pg/ml) was not age related, but resting E (pg/ml) was higher in male subjects 68-77 yr old (group III) than in those aged 22-37 (group I) or 44-55 yr (group II), P less than 0.01. Maximal HR (beats/min) showed a strong inverse relationship to age (203.5 - 0.65 age, r = -0.80, P less than 0.001). Peak VO2 in milliliters per kilogram total body weight per minute decreased with age (47.7 - 0.23 age, r = -0.71, P less than 0.001). At maximal effort both NE (P less than 0.01) and E (P less than 0.05) were higher in group III than in either of the younger groups. At submaximal work levels NE and E also increased with age, and when normalized for relative effort at loads between 45 and 80% of peak VO2 both NE and E were higher in the group III male subjects, although statistical significance was reached for NE (P less than 0.01) but not for E (P = 0.09).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4055584     DOI: 10.1152/jappl.1985.59.4.1033

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  33 in total

Review 1.  Nuclear cardiology approaches to defining normal and abnormal cardiovascular aging.

Authors:  J L Fleg; S P Schulman
Journal:  J Nucl Cardiol       Date:  1999 Sep-Oct       Impact factor: 5.952

2.  Cardiac arrhythmia at high altitude: the progressive effect of aging.

Authors:  J K Alexander
Journal:  Tex Heart Inst J       Date:  1999

3.  Age and training effects on the lactate kinetics of master athletes during maximal exercise.

Authors:  J Massé-Biron; J Mercier; K Collomp; J M Hardy; C Préfaut
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

Review 4.  Risk: benefit of treating high blood pressure in older adults.

Authors:  Omar Mukhtar; Stephen H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

5.  Are older adults less or more physiologically reactive? A meta-analysis of age-related differences in cardiovascular reactivity to laboratory tasks.

Authors:  Bert N Uchino; Wendy Birmingham; Cynthia A Berg
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2010-01-06       Impact factor: 4.077

Review 6.  Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging.

Authors:  Naranjan S Dhalla; Shashanka Rangi; Andrea P Babick; Shelley Zieroth; Vijayan Elimban
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

Review 7.  Arterial Ventricular Uncoupling With Age and Disease and Recoupling With Exercise.

Authors:  Paul D Chantler
Journal:  Exerc Sport Sci Rev       Date:  2017-04       Impact factor: 6.230

8.  Age-associated abnormalities of intrinsic automaticity of sinoatrial nodal cells are linked to deficient cAMP-PKA-Ca(2+) signaling.

Authors:  Jie Liu; Syevda Sirenko; Magdalena Juhaszova; Steven J Sollott; Shweta Shukla; Yael Yaniv; Edward G Lakatta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-14       Impact factor: 4.733

9.  Age-associated changes in beta-adrenergic modulation on rat cardiac excitation-contraction coupling.

Authors:  R P Xiao; H A Spurgeon; F O'Connor; E G Lakatta
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

Review 10.  Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease.

Authors:  Mario Cazzola; Maria G Matera; Claudio F Donner
Journal:  Drugs       Date:  2005       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.